Fernandina Beach, FL – April 21, 2025 – GalenusRx, a leader in innovative medication safety assessment and management solutions, welcomes Bryan Rotella, J.D., founder of GenCo Legal®, to its Advisory Board.
“I am thrilled to join the advisory board of GalenusRx. Their commitment to innovative medication safety and personalized treatment plans aligns perfectly with my mission to promote Legal Wellness™ and value-based legal outcomes. I look forward to contributing my expertise to help GalenusRx continue to lead the way in healthcare solutions,” said Rotella.
Bryan brings extensive legal experience and a deep understanding of business leadership. He began his career at Masry & Vititoe, the firm made famous by the Erin Brockovich case, and went on to become a high-exposure trial lawyer. Over the course of his career, he has advised boards on liability and compliance, served as general counsel to billion-dollar, private equity-backed healthcare companies, and pioneered the Value Based Law™ model. In response to evolving technology, he has also become known nationally as the A.I. Revolution Lawyer™.
His mission is to help business leaders and their organizations stay legally well and out of the “Legal ER.” He has been featured on Fox News, Fox Business, CNN, NewsNation, and keynote stages across the country, where he shares insights on the evolving legal landscape. Bryan is recognized for helping executive audiences “make the case for themselves” on emerging legal risks and for guiding organizations to prioritize Legal Wellness™.
“We are excited to welcome Bryan Rotella to our advisory board. His extensive legal background and pioneering work will be invaluable as we continue to enhance our APPRAISE™ platform and ensure the highest standards of medication safety for our patients and return on investment for our value-based care clients,” said Peter Panageas, Chief Commercial Officer, GalenusRx.
GalenusRx’s proprietary platform, APPRAISE™, provides comprehensive risk assessments by analyzing drug-drug, multi-drug, drug-gene, and drug-disease interactions. This innovative approach ensures that patients receive the safest and most effective medication regimens tailored to each individual, including their genetic make-up. GalenusRx creates personalized treatment plans that drive better outcomes and total medical cost savings.
